Determination of an angiotensin II-regulated proteome in primary human kidney cells by stable isotope labeling of amino acids in cell culture (SILAC)

Journal of Biological Chemistry

Volumn 288, Issue 34, 2013, Pages 24834-24847

  Konvalinka, Ana ^a,b,f   Zhou, Joyce ^a   Dimitromanolakis, Apostolos ^a,c   Drabovich, Andrei P ^a,c   Fang, Fei ^a   Gurley, Susan ^d   Coffman, Thomas ^d   John, Rohan ^a   Zhang, Shao Ling ^e   Diamandis, Eleftherios P ^a,c   Scholey, James W ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^f TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CELL CULTURE; GENES; ISOTOPES; MAMMALS; MASS SPECTROMETRY; PORPHYRINS; PROTEOMICS;

EXPERIMENTAL MODELS; GENE ONTOLOGY TERMS; HEME OXYGENASE-1; RENIN-ANGIOTENSIN SYSTEM; SELECTED REACTION MONITORING; SPECTROMETRY TECHNIQUE; STABLE-ISOTOPE LABELING; URINARY EXCRETION;

PROTEINS;

AMINO ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; HEME OXYGENASE 1; PROTEOME;

ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; ENZYME REGULATION; FEMALE; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; ISOTOPE LABELING; KIDNEY CELL; KIDNEY PROXIMAL TUBULE; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEOMICS; SELECTED REACTION MONITORING; UPREGULATION; URINARY EXCRETION; WILD TYPE;

ANIMALIA; MUS;

EID: 84883180458     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.485326     Document Type: Article

References (91)

1. Wolf, G., and Ziyadeh, F. N. (1997) The role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms. Am. J. Kidney Dis. 29, 153-163
2. Knight, S. F., and Imig, J. D. (2007) Obesity, insulin resistance, and renal function. Microcirculation 14, 349-362
3. Lewis, E. J., Hunsicker, L. G., Bain, R. P., and Rohde, R. D. (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N. Engl. J. Med. 329, 1456-1462
4. Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., and Raz, I. (2001) Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N. Engl. J. Med. 345, 851-860
5. Wolf, G., and Ritz, E. (2005) Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications. Kidney Int. 67, 799-812
6. Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H. H., Remuzzi, G., Snapinn, S. M., Zhang, Z., and Shahinfar, S. (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N. Engl. J. Med. 345, 861-869
7. Kunz, R., Friedrich, C., Wolbers, M., and Mann, J. F. (2008) Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease. Ann. Intern. Med. 148, 30-48
8. Laverman, G. D., Navis, G., Henning, R. H., de Jong, P. E., and de Zeeuw, D. (2002) Dual renin-angiotensin system blockade at optimal doses for proteinuria. Kidney Int. 62, 1020-1025
9. Russo, D., Pisani, A., Balletta, M. M., De Nicola, L., Savino, F. A., Andreucci, M., and Minutolo, R. (1999) Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy. Am. J. Kidney Dis. 33, 851-856
10. Mann, J. F., Schmieder, R. E., McQueen, M., Dyal, L., Schumacher, H., Pogue, J., Wang, X., Maggioni, A., Budaj, A., Chaithiraphan, S., Dickstein, K., Keltai, M., Metsärinne, K., Oto, A., Parkhomenko, A., Piegas, L. S., Svendsen, T. L., Teo, K. K., Yusuf, S., and ONTARGET investigators (2008) Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet 372, 547-553
11. Parving, H. H., Brenner, B. M., McMurray, J. J., de Zeeuw, D., Haffner, S. M., Solomon, S. D., Chaturvedi, N., Persson, F., Desai, A. S., Nicolaides, M., Richard, A., Xiang, Z., Brunel, P., and Pfeffer, M. A. (2012) Cardiorenal end points in a trial of Aliskiren for type 2 diabetes. N. Engl. J. Med. 367, 2204-2213
12. Zimmerman, J. B., Robertson, D., and Jackson, E. K. (1987) Angiotensin II-noradrenergic interactions in renovascular hypertensive rats. J. Clin. Invest. 80, 443-457
13. Purdy, R. E., and Weber, M. A. (1988) Angiotensin II amplification of α-adrenergic vasoconstriction: role of receptor reserve. Circ. Res. 63, 748-757
14. Wilcox, C. S., Welch, W. J., and Snellen, H. (1991) Thromboxane mediates renal hemodynamic response to infused angiotensin II. Kidney Int. 40, 1090-1097
15. Wagner, C., Jensen, B. L., Krämer, B. K., and Kurtz, A. (1998) Control of the renal renin system by local factors. Kidney Int. Suppl. 67, S78-S83
16. Dzau, V. J. (1993) Tissue renin-angiotensin system in myocardial hypertrophy and failure. Arch. Intern. Med. 153, 937-942
17. Kifor, I., Moore, T. J., Fallo, F., Sperling, E., Chiou, C. Y., Menachery, A., and Williams, G. H. (1991) Potassium-stimulated angiotensin release from superfused adrenal capsules and enzymatically dispersed cells of the zona glomerulosa. Endocrinology 129, 823-831
18. Naftilan, A. J., Zuo, W. M., Inglefinger, J., Ryan, T. J., Jr., Pratt, R. E., and Dzau, V. J. (1991) Localization and differential regulation of angiotensinogen mRNA expression in the vessel wall. J. Clin. Invest. 87, 1300-1311
19. Ingelfinger, J. R., Zuo, W. M., Fon, E. A., Ellison, K. E., and Dzau, V. J. (1990) In situ hybridization evidence for angiotensinogen messengerRNA in the rat proximal tubule. An hypothesis for the intrarenal renin angiotensin system. J. Clin. Invest. 85, 417-423
20. Seikaly, M. G., Arant, B. S., Jr., and Seney, F. D., Jr. (1990) Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. J. Clin. Invest. 86, 1352-1357
21. Kobori, H., Nangaku, M., Navar, L. G., and Nishiyama, A. (2007) The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol. Rev. 59, 251-287
22. Navar, L. G., and Nishiyama, A. (2004) Why are angiotensin concentrations so high in the kidney? Curr. Opin. Nephrol. Hypertens 13, 107-115
23. Siragy, H. M., and Carey, R. M. (2010) Role of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease. Am. J. Nephrol. 31, 541-550
24. Bader, M., and Ganten, D. (2008) Update on tissue renin-angiotensin systems. J. Mol. Med. 86, 615-621
25. Imig, J. D., Navar, G. L., Zou, L. X., O'Reilly, K. C., Allen, P. L., Kaysen, J. H., Hammond, T. G., and Navar, L. G. (1999) Renal endosomes contain angiotensin peptides, converting enzyme, and AT(1A) receptors. Am. J. Physiol. 277, F303-F311
26. Zhuo, J. L., Imig, J. D., Hammond, T. G., Orengo, S., Benes, E., and Navar, L. G. (2002) AngII accumulation in rat renal endosomes during AngIIinduced hypertension: role of AT(1) receptor. Hypertension 39, 116-121
27. Gurley, S. B., Riquier-Brison, A. D., Schnermann, J., Sparks, M. A., Allen, A. M., Haase, V. H., Snouwaert, J. N., Le, T. H., McDonough, A. A., Koller, B. H., and Coffman, T. M. (2011) AT1A angiotensin receptors in the renal proximal tubule regulate blood pressure. Cell Metab. 13, 469-475
28. Zhuo, J. L., and Li, X. C. (2007) Novel roles of intracrine angiotensin II and signalling mechanisms in kidney cells. J. Renin Angiotensin Aldosterone Syst. 8, 23-33
29. Johnston, C. I. (1992) Franz Volhard Lecture. Renin-angiotensin system: a dual tissue and hormonal system for cardiovascular control. J. Hypertens. Suppl. 10, S13-26
30. Dzau, V. J. (2001) Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension 37, 1047-1052
31. Mendelsohn, F. A. (1982) Angiotensin II: evidence for its role as an intrarenal hormone. Kidney Int. Suppl. 12, S78-81
32. Tang, S. S., Jung, F., Diamant, D., Brown, D., Bachinsky, D., Hellman, P., and Ingelfinger, J. R. (1995) Temperature-sensitive SV40 immortalized rat proximal tubule cell line has functional renin-angiotensin system. Am. J. Physiol. 268, F435-F446
33. Ingelfinger, J. R., Jung, F., Diamant, D., Haveran, L., Lee, E., Brem, A., and Tang, S. S. (1999) Rat proximal tubule cell line transformed with origindefective SV40 DNA: autocrine ANG II feedback. Am. J. Physiol. 276, F218-F227
34. Harrison-Bernard, L. M., Zhuo, J., Kobori, H., Ohishi, M., and Navar, L. G. (2002) Intrarenal AT(1) receptor and ACE binding in ANG II-induced hypertensive rats. Am. J. Physiol. Renal Physiol. 282, F19-F25
35. Ong, S. E., Blagoev, B., Kratchmarova, I., Kristensen, D. B., Steen, H., Pandey, A., and Mann, M. (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 1, 376-386
36. Makawita, S., Smith, C., Batruch, I., Zheng, Y., Ruckert, F., Grutzmann, R., Pilarsky, C., Gallinger, S., and Diamandis, E. P. (2011) Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers. Mol. Cell. Proteomics 10, M111 008599
37. Cox, J., and Mann, M. (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367-1372
38. MacLean, B., Tomazela, D. M., Shulman, N., Chambers, M., Finney, G. L., Frewen, B., Kern, R., Tabb, D. L., Liebler, D. C., and MacCoss, M. J. (2010) Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26, 966-968
39. Drabovich, A. P., Jarvi, K., and Diamandis, E. P. (2011) Verification of male infertility biomarkers in seminal plasma by multiplex selected reaction monitoring assay. Mol. Cell. Proteomics 10, M110 004127
40. Drabovich, A. P., and Diamandis, E. P. (2010) Combinatorial peptide libraries facilitate development of multiple reaction monitoring assays for low abundance proteins. J. Proteome Res. 9, 1236-1245
41. Drabovich, A. P., Pavlou, M. P., Dimitromanolakis, A., and Diamandis, E. P. (2012) Quantitative analysis of energy metabolic pathways in MCF-7 breast cancer cells by selected reaction monitoring assay. Mol. Cell. Proteomics 11, 422-434
42. Maclean, B., Tomazela, D. M., Abbatiello, S. E., Zhang, S., Whiteaker, J. R., Paulovich, A. G., Carr, S. A., and Maccoss, M. J. (2010) Effect of collision energy optimization on the measurement of peptides by selected reaction monitoring (SRM) mass spectrometry. Anal. Chem. 82, 10116-10124
43. Maere, S., Heymans, K., and Kuiper, M. (2005) BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 21, 3448-3449
44. Cline, M. S., Smoot, M., Cerami, E., Kuchinsky, A., Landys, N., Workman, C., Christmas, R., Avila-Campilo, I., Creech, M., Gross, B., Hanspers, K., Isserlin, R., Kelley, R., Killcoyne, S., Lotia, S., Maere, S., Morris, J., Ono, K., Pavlovic, V., Pico, A. R., Vailaya, A., Wang, P. L., Adler, A., Conklin, B. R., Hood, L., Kuiper, M., Sander, C., Schmulevich, I., Schwikowski, B., Warner, G. J., Ideker, T., and Bader, G. D. (2007) Integration of biological networks and gene expression data using Cytoscape. Nat. Protoc. 2, 2366-2382
45. Liu, G. C., Oudit, G. Y., Fang, F., Zhou, J., and Scholey, J. W. (2012) Angiotensin-(1-7)-induced activation of ERK1/2 is cAMP/protein kinase A-dependent in glomerular mesangial cells. Am. J. Physiol. Renal Physiol. 302, F784-F790
46. Oudit, G. Y., Liu, G. C., Zhong, J., Basu, R., Chow, F. L., Zhou, J., Loibner, H., Janzek, E., Schuster, M., Penninger, J. M., Herzenberg, A. M., Kassiri, Z., and Scholey, J. W. (2010) Human recombinant ACE2 reduces the progression of diabetic nephropathy. Diabetes 59, 529-538
47. Taussky, H. H. (1954) A microcolorimetric determination of creatine in urine by the Jaffe reaction. J. Biol. Chem. 208, 853-861
48. Rankin, E. B., Tomaszewski, J. E., and Haase, V. H. (2006) Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor. Cancer Res. 66, 2576-2583
49. Rangasamy, T., Cho, C. Y., Thimmulappa, R. K., Zhen, L., Srisuma, S. S., Kensler, T. W., Yamamoto, M., Petrache, I., Tuder, R. M., and Biswal, S. (2004) Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J. Clin. Invest. 114, 1248-1259
50. He, X., and Ma, Q. (2012) Redox regulation by nuclear factor erythroid 2-related factor 2: gatekeeping for the basal and diabetes-induced expression of thioredoxin-interacting protein. Mol. Pharmacol. 82, 887-897
51. Zhang, J., Dinh, T. N., Kappeler, K., Tsaprailis, G., and Chen, Q. M. (2012) La autoantigen mediates oxidant induced de novo Nrf2 protein translation. Mol. Cell. Proteomics 11, M111.015032
52. Merico, D., Isserlin, R., Stueker, O., Emili, A., and Bader, G. D. (2010) Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS One 5, e13984
53. Makhanova, N. A., Crowley, S. D., Griffiths, R. C., and Coffman, T. M. (2010) Gene expression profiles linked to AT1 angiotensin receptors in the kidney. Physiol. Genomics 42A, 211-218
54. Aminzadeh, M. A., Sato, T., and Vaziri, N. D. (2012) Participation of endoplasmic reticulum stress in the pathogenesis of spontaneous glomerulosclerosis-role of intra-renal angiotensin system. Transl. Res. 160, 309-318
55. Bhaskaran, M., Reddy, K., Radhakrishanan, N., Franki, N., Ding, G., and Singhal, P. C. (2003) Angiotensin II induces apoptosis in renal proximal tubular cells. Am. J. Physiol. Renal Physiol. 284, F955-F965
56. Weidekamm, C., Hauser, P., Hansmann, C., Schwarz, C., Klingler, H., Mayer, G., and Oberbauer, R. (2002) Effects of AT1 and AT2 receptor blockade on angiotensin II-induced apoptosis of human renal proximal tubular epithelial cells. Wien Klin. Wochenschr. 114, 725-729
57. Liu, F., Brezniceanu, M. L., Wei, C. C., Chénier, I., Sachetelli, S., Zhang, S. L., Filep, J. G., Ingelfinger, J. R., and Chan, J. S. (2008) Overexpression of angiotensinogen increases tubular apoptosis in diabetes. J. Am. Soc. Nephrol. 19, 269-280
58. Lodha, S., Dani, D., Mehta, R., Bhaskaran, M., Reddy, K., Ding, G., and Singhal, P. C. (2002) Angiotensin II-induced mesangial cell apoptosis: role of oxidative stress. Mol. Med. 8, 830-840
59. Susztak, K., Raff, A. C., Schiffer, M., and Böttinger, E. P. (2006) Glucoseinduced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 55, 225-233
60. Reblin, T., Donarski, N., Fineder, L., Bräsen, J. H., Dieplinger, H., Thaiss, F., Stahl, R. A., Beisiegel, U., and Wolf, G. (2001) Renal handling of human apolipoprotein(a) and its fragments in the rat. Am. J. Kidney Dis. 38, 619-630
61. Wanner, C., Greiber, S., Krämer-Guth, A., Heinloth, A., and Galle, J. (1997) Lipids and progression of renal disease: role of modified low density lipoprotein and lipoprotein (a). Kidney Int. Suppl. 63, S102-106
62. Zager, R. A., Burkhart, K. M., Johnson, A. C., and Sacks, B. M. (1999) Increased proximal tubular cholesterol content: implications for cell injury and "acquired cytoresistance". Kidney Int. 56, 1788-1797
63. Schelling, P., Fischer, H., and Ganten, D. (1991) Angiotensin and cell growth: a link to cardiovascular hypertrophy? J. Hypertens. 9, 3-15
64. Wolf, G., and Neilson, E. G. (1990) Angiotensin II induces cellular hyper-trophy in cultured murine proximal tubular cells. Am. J. Physiol. 259, F768-F777
65. Kim, J. A., Jang, H. J., Martinez-Lemus, L. A., and Sowers, J. R. (2012) Activation of mTOR/p70S6 kinase by ANG II inhibits insulin-stimulated endothelial nitric oxide synthase and vasodilation. Am. J. Physiol. Endocrinol. Metab. 302, E201-E208
66. Muller, D. N., Shagdarsuren, E., Park, J. K., Dechend, R., Mervaala, E., Hampich, F., Fiebeler, A., Ju, X., Finckenberg, P., Theuer, J., Viedt, C., Kreuzer, J., Heidecke, H., Haller, H., Zenke, M., and Luft, F. C. (2002) Immunosuppressive treatment protects against angiotensin II-induced renal damage. Am. J. Pathol. 161, 1679-1693
67. Ruiz-Ortega, M., Rupérez, M., Esteban, V., Rodríguez-Vita, J., Sánchez-López, E., Carvajal, G., and Egido, J. (2006) Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol. Dial. Transplant. 21, 16-20
68. Finckenberg, P., Inkinen, K., Ahonen, J., Merasto, S., Louhelainen, M., Vapaatalo, H., Müller, D., Ganten, D., Luft, F., and Mervaala, E. (2003) Angiotensin II induces connective tissue growth factor gene expression via calcineurin-dependent pathways. Am. J. Pathol. 163, 355-366
69. Lautrette, A., Li, S., Alili, R., Sunnarborg, S. W., Burtin, M., Lee, D. C., Friedlander, G., and Terzi, F. (2005) Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach. Nat. Med. 11, 867-874
70. Carvajal, G., Rodríguez-Vita, J., Rodrigues-Díez, R., Sánchez-López, E., Rupérez, M., Cartier, C., Esteban, V., Ortiz, A., Egido, J., Mezzano, S. A., and Ruiz-Ortega, M. (2008) Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation. Kidney Int. 74, 585-595
71. Yang, F., Chung, A. C., Huang, X. R., and Lan, H. Y. (2009) Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-β-dependent and-independent Smad pathways: the role of Smad3. Hypertension 54, 877-884
72. Haugen, E. N., Croatt, A. J., and Nath, K. A. (2000) Angiotensin II induces renal oxidant stress in vivo and heme oxygenase-1 in vivo and in vitro. Kidney Int. 58, 144-152
73. Alam, J., Killeen, E., Gong, P., Naquin, R., Hu, B., Stewart, D., Ingelfinger, J. R., and Nath, K. A. (2003) Heme activates the heme oxygenase-1 gene in renal epithelial cells by stabilizing Nrf2. Am. J. Physiol. Renal Physiol. 284, F743-F752
74. Aizawa, T., Ishizaka, N., Taguchi Ji., Nagai, R., Mori, I., Tang, S. S., Ingelfinger, J. R., and Ohno, M. (2000) Heme oxygenase-1 is up-regulated in the kidney of angiotensin II-induced hypertensive rats: possible role in renoprotection. Hypertension 35, 800-806
75. Aizawa, T., Ishizaka, N., Kurokawa, K., Nagai, R., Nakajima, H., Taguchi, J., and Ohno, M. (2001) Different effects of angiotensin II and catecholamine on renal cell apoptosis and proliferation in rats. Kidney Int. 59, 645-653
76. Ohashi, N., Katsurada, A., Miyata, K., Satou, R., Saito, T., Urushihara, M., and Kobori, H. (2009) Role of activated intrarenal reactive oxygen species and renin-angiotensin system in IgA nephropathy model mice. Clin. Exp. Pharmacol. Physiol. 36, 750-755
77. Kobori, H., Katsurada, A., Ozawa, Y., Satou, R., Miyata, K., Hase, N., Suzaki, Y., and Shoji, T. (2007) Enhanced intrarenal oxidative stress and angiotensinogen in IgA nephropathy patients. Biochem. Biophys. Res. Commun. 358, 156-163
78. da Silva, J. L., Zand, B. A., Yang, L. M., Sabaawy, H. E., Lianos, E., and Abraham, N. G. (2001) Heme oxygenase isoform-specific expression and distribution in the rat kidney. Kidney Int. 59, 1448-1457
79. Chang, S. Y., Chen, Y. W., Chenier, I., Tran Sle, M., and Zhang, S. L. (2011) Angiotensin II type II receptor deficiency accelerates the development of nephropathy in type I diabetes via oxidative stress and ACE2. Exp. Diabetes Res. 2011, 521076
80. Zager, R. A., Johnson, A. C., and Becker, K. (2012) Plasma and urinary heme oxygenase-1 in AKI. J. Am. Soc. Nephrol. 23, 1048-1057
81. Yokoyama, T., Shimizu, M., Ohta, K., Yuno, T., Okajima, M., Wada, T., Toma, T., Koizumi, S., and Yachie, A. (2011) Urinary heme oxygenase-1 as a sensitive indicator of tubulointerstitial inflammatory damage in various renal diseases. Am. J. Nephrol. 33, 414-420
82. Reams, G., Villarreal, D., Wu, Z., and Bauer, J. H. (1994) Urinary angiotensin II: a marker of renal tissue activity? Nephron 67, 450-458
83. Vos, P. F., Boer, P., Braam, B., and Koomans, H. A. (1994) The origin of urinary angiotensins in humans. J. Am. Soc. Nephrol. 5, 215-223
84. Kobori, H., Harrison-Bernard, L. M., and Navar, L. G. (2002) Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production. Kidney Int. 61, 579-585
85. Kobori, H., Nishiyama, A., Harrison-Bernard, L. M., and Navar, L. G. (2003) Urinary angiotensinogen as an indicator of intrarenal angiotensin status in hypertension. Hypertension 41, 42-49
86. Yamamoto, T., Nakagawa, T., Suzuki, H., Ohashi, N., Fukasawa, H., Fujigaki, Y., Kato, A., Nakamura, Y., Suzuki, F., and Hishida, A. (2007) Urinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney disease. J. Am. Soc. Nephrol. 18, 1558-1565
87. Nishiyama, A., Konishi, Y., Ohashi, N., Morikawa, T., Urushihara, M., Maeda, I., Hamada, M., Kishida, M., Hitomi, H., Shirahashi, N., Kobori, H., and Imanishi, M. (2011) Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy. Nephrol. Dial. Transplant. 26, 170-177
88. Mills, K. T., Kobori, H., Hamm, L. L., Alper, A. B., Khan, I. E., Rahman, M., Navar, L. G., Liu, Y., Browne, G. M., Batuman, V., He, J., and Chen, J. (2012) Increased urinary excretion of angiotensinogen is associated with risk of chronic kidney disease. Nephrol. Dial. Transplant. 27, 3176-3181
89. Lifton, R. P. (1995) Genetic determinants of human hypertension. Proc. Natl. Acad. Sci. U.S.A. 92, 8545-8551
90. Matsusaka, T., Niimura, F., Shimizu, A., Pastan, I., Saito, A., Kobori, H., Nishiyama, A., and Ichikawa, I. (2012) Liver angiotensinogen is the primary source of renal angiotensin II. J. Am. Soc. Nephrol. 23, 1181-1189
91. Vizcaíno, J. A., Côté, R. G., Csordas, A., Dianes, J. A., Fabregat, A., Foster, J. M., Griss, J., Alpi, E., Birim, M., Contell, J., O'Kelly, G., Schoenegger, A., Ovelleiro, D., Pérez-Riverol, Y., Reisinger, F., Ríos, D., Wang, R., and Hermjakob, H. (2013) The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res. 41, D1063-D1069